trial · primary record
BL-B01D1
Non-squamous Non-small Cell Lung Cancer
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 166 |
| Primary completion | 2029-12 |
| Primary endpoint | Phase II Part_A: Treatment Emergent Adverse Event (TEAE) |
| Registry ID | NCT07739186 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:43:07.513Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07739186
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Bl-B01d1 · compound